Eledon Pharmaceuticals, Inc. Restricted Cash and Cash Equivalents, Noncurrent
Eledon Pharmaceuticals, Inc. (ELDN) had Restricted Cash and Cash Equivalents, Noncurrent of $70.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2017-11-08
- 2017-09-30: Restricted Cash and Cash Equivalents, Noncurrent $70.00K.
- 2017-06-30: Restricted Cash and Cash Equivalents, Noncurrent $70.00K.
- 2017-03-31: Restricted Cash and Cash Equivalents, Noncurrent $120.00K.
- 2016-12-31: Restricted Cash and Cash Equivalents, Noncurrent $120.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2017-09-30 | $70.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $70.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $120.00K 10-Q · filed 2017-05-03 |
| 2016-12-31 | $120.00K 10-Q · filed 2017-05-03 |
| 2016-09-30 | $270.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $270.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $270.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $270.00K 10-K · filed 2017-03-03 |
| 2015-09-30 | $270.00K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $270.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $200.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $200.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | $200.00K 10-Q · filed 2014-11-13 |
| 2013-12-31 | $50.00K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |